Literature DB >> 22763459

Clinical profile, quality of care, and recurrence in Arab-American and Caucasians prostate cancer patients in Michigan.

Ahmad H Moussawi1, May Yassine, Subhojit Dey, Amr S Soliman.   

Abstract

Prostate cancer is the most common cancer among men in the United States with striking differences in incidence and mortality among ethnic groups. Michigan has one of the largest concentrations of Arab Americans (AAs) in the U.S. and little is known about this ethnic minority with respect to prostate cancer. This study investigated differences in clinical profile, quality of care, and recurrence among prostate cancer survivors comparing AAs and Caucasian Americans (CAs). Participants in this study included 2499 prostate cancer survivors from the Michigan Cancer Registry from 1985 to 2004. Participants completed surveys regarding health-seeking behavior, post-treatment symptoms, quality of care and recurrence. Ethnicity was self-reported and AAs and CAs were compared with respect to clinical profile, quality of care, and recurrence. There were 52 AAs and 1886 CAs patients with AAs being younger ([Formula: see text] age 68.3 ± SD 21.4 years, [Formula: see text] age 72.3 ± SD 14.1 years, for AAs and CAs, respectively) (P = 0.05). AAs had lower socioeconomic standard than CAs (34 vs. 10.6 %, <$20,000 yearly income/year; for AAs vs. CAs, respectively) (P < 0.0001). AAs reported poorer health than AAs (7.7 vs. 3.0 % for AAs vs. CAs, respectively) (P < 0.0001). AAs were more likely to visit specialists for prostate follow-up (44.5 vs. 19.7 % visited a specialist, for AAs vs. CAs respectively) (P < 0.0001) and received supplementary healthcare workers (13 % of AAs vs. 3.1 % CAs) (P = 0.032). In addition, AAs reported higher occurrence of urinary incontinence compared to CAs (67.4 vs. 60.4 %, for AAs vs. CAs, respectively) (P = 0.001). Ethnic background was not a predictor of recurrence [(Odds ratio (OR) = 1.1 (95 % confidence intervals CI = 0.40, 2.9)] (P = 0.873) even after adjusting for age, PSA levels within the last 2 years, metastasis and hormonal therapy. While AAs prostate cancer patients were different from CAs in age, income, seeking medical care, and health reporting, ethnic background was not a predictor of recurrence. Future studies of the impact of socioeconomic, demographic and cultural factors, and health care seeking behavior on long-term survival of prostate cancer in AAs and other ethnic minorities are warranted.

Entities:  

Mesh:

Year:  2013        PMID: 22763459      PMCID: PMC4164151          DOI: 10.1007/s10903-012-9662-y

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  21 in total

1.  A multilevel analysis of socioeconomic status and prostate cancer risk.

Authors:  Maureen Sanderson; Ann L Coker; Adriana Perez; Xianglin L Du; Gerson Peltz; Mary K Fadden
Journal:  Ann Epidemiol       Date:  2006-07-12       Impact factor: 3.797

Review 2.  [Recurrence of prostate cancer--value of salvage radiotherapy].

Authors:  C Belka; U Ganswindt
Journal:  Urologe A       Date:  2006-10       Impact factor: 0.639

3.  Microsatellite instability and mismatch repair defects in cancer.

Authors:  D C Thomas; A Umar; T A Kunkel
Journal:  Mutat Res       Date:  1996-02-19       Impact factor: 2.433

4.  The rationale, design, and implementation of the American Cancer Society's studies of cancer survivors.

Authors:  Tenbroeck Smith; Kevin D Stein; C Christina Mehta; Chiewkwei Kaw; James L Kepner; Trent Buskirk; Jeremy Stafford; Frank Baker
Journal:  Cancer       Date:  2007-01-01       Impact factor: 6.860

5.  Mortality rates among Arab Americans in Michigan.

Authors:  Florence J Dallo; Kendra Schwartz; Julie J Ruterbusch; Jason Booza; David R Williams
Journal:  J Immigr Minor Health       Date:  2012-04

6.  Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.

Authors:  J T Wei; R L Dunn; M S Litwin; H M Sandler; M G Sanda
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

7.  Explaining the race difference in prostate cancer stage at diagnosis.

Authors:  Beth A Jones; Wen-Liang Liu; Andre B Araujo; Stanislav V Kasl; Stephanie N Silvera; Hosanna Soler-Vilá; Mary G M Curnen; Robert Dubrow
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09-30       Impact factor: 4.254

8.  Epidemiology of prostate cancer in United Arab Emirates.

Authors:  M Ghafoor; R Schuyten; A Bener
Journal:  Med J Malaysia       Date:  2003-12

Review 9.  Prostate cancer and urinary incontinence.

Authors:  Brian A Parsons; Simon Evans; Mark P Wright
Journal:  Maturitas       Date:  2009-07-16       Impact factor: 4.342

Review 10.  Rising prostate-specific antigen after primary treatment of prostate cancer: sequential hormone manipulation.

Authors:  Hans-Peter Schmid; Franz U Keuler; Jens E Altwein
Journal:  Urol Int       Date:  2007       Impact factor: 2.089

View more
  3 in total

1.  Clinicopathological features, treatment and outcome of Omani patients with localised prostate cancer.

Authors:  Shiyam Kumar; Ikram A Burney; Namrata Satyapal; Joseph Kunju; Mohamed Salim Al-Marhoon; Khurrum Mutahir Siddiqui
Journal:  Arab J Urol       Date:  2020-07-06

2.  Perspectives of multisectoral community stakeholders on Arab American cancer patients' needs and suggested interventions.

Authors:  Perla Chebli; Katherine Reyes; Naoko Muramatsu; Karriem Watson; Marian Fitzgibbon; Sarah Abboud; Yamilé Molina
Journal:  Support Care Cancer       Date:  2021-03-24       Impact factor: 3.603

3.  The Health of Arab Americans in the United States: An Updated Comprehensive Literature Review.

Authors:  Nadia N Abuelezam; Abdulrahman M El-Sayed; Sandro Galea
Journal:  Front Public Health       Date:  2018-09-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.